ASH 2018 | Highlights on myelofibrosis from ASH

Claire Harrison

Claire Harrison, MD, FRCP, FRCPath, of the Guy’s and St Thomas’ NHS Foundation Trust, London, UK, shares an overview of key updates in treatment for myelofibrosis, including ongoing clinical trials, novel treatment combinations, and developments from the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA.

Share this video